FDA Approves New Drug for Advanced Prostate Cancer
FDA approves new drug for advanced prostate cancer
Filed under: drug treatment programs maryland
The U.S. Food and Drug Administration today approved Xofigo (radium Ra 223 dichloride) to treat men with symptomatic late-stage (metastatic) castration-resistant prostate cancer that has spread to bones but not to other organs. … The FDA reviewed …
Read more on FDA.gov
Tech Council of Maryland Names GlycoMimetics CEO Rachel King as 2013 …
Filed under: drug treatment programs maryland
“The TCM Tech Awards is a prestigious recognition program for technology and life science organizations in Maryland. It is a tremendous honor to be named Executive of the Year,” said Ms. King. “In the ten years since I co-founded GlycoMimetics, I have …
Read more on EON: Enhanced Online News (press release)
Additional macitentan (Opsumit) data in pulmonary arterial hypertension …
Filed under: drug treatment programs maryland
ALLSCHWIL/BASEL, Switzerland I May 17, 2013 IActelion (SIX: ATLN) today announced that further data for its investigational drug macitentan (Opsumit ®) will be presented at the American Thoracic Society (ATS) International Congress, Philadelphia, USA …
Read more on PipelineReview.com (press release)
University of Maryland Medical Center launches genetic-testing program for …
Filed under: drug treatment programs maryland
Patients with coronary artery disease who undergo treatment at the University of Maryland Medical Center now can receive long-term therapy based on information found in their genes. As part of a new personalized medicine initiative …
Read more on EurekAlert (press release)